Parabilis Medicines Inc (PBLS) Stock Price, Quote, News & History

PBLSNASDAQ
$26.59
1.586.32%
At close: Jun 15, 5:00 PM EST
$29.29
4.2817.11%
Pre-Market: 9:03 AM EST
Loading...

Key Statistics

Open
-
Close
$26.59
Volume / Avg.
44.88K / 2.56M
Day Range
- - -
52 Wk Range
24.51 - 34.47
Market Cap
$3.58B
P/E Ratio
-
Dividend Yield
-
Exchange
NASDAQ
RSI
-
Short Interest
-
Days to Cover
-

Recent Parabilis Medicines Inc News

No news found

Financials

Quarterly
Annual
Name
Revenue
Change
Gross
Change
EBITDA
Change
EBIT
Change
Earnings
Change

Cash Flows

Operating Cash Flow (TTM)
-138.76M
Investing Cash Flow (TTM)
32.70M
Financing Cash Flow (TTM)
347.99M
Free Cash Flow (TTM)
-139.36M
Capital Expenditure (TTM)
-601.00K
Net Change in Cash (TTM)
241.93M

Valuation Metrics

Enterprise Value
$3.78B
PE Ratio (TTM)
-
PE Ratio (FWD)
-
PEG Ratio (TTM)
-
PS Ratio (TTM)
-
PB Ratio (TTM)
-
Earnings Yield % (TTM)
-6.70%
Earnings Yield % (FWD)
-
EV / EBITDA (TTM)
-
Price / EBITDA (TTM)
-
Price / Free Cash Flow (TTM)
-
Book Value / Share
-$4.66

Company Debt

Total Debt
$9.40M
LT Debt
-
LT Debt Issuance (TTM)
-
LT Debt Repayment (TTM)
-$3.10M
Total Cash
$329.04M
Debt to Equity
-
Issuance of Debt (TTM)
-$3.10M
Repayment of Debt (TTM)
-$6.85M

Key Statistics

Open
-
Close
$26.59
Volume / Avg.
44.88K / 2.56M
Day Range
- - -
52 Wk Range
24.51 - 34.47
Market Cap
$3.58B
P/E Ratio
-
Dividend Yield
-
Exchange
NASDAQ
RSI
-
Short Interest
-
Days to Cover
-

About

Sector
N/A
Industry
N/A
Parabilis Medicines Inc s a clinical-stage biopharmaceutical company. It is focused on the development of medicines targeting protein interactions associated with human diseases. It uses a proprietary platform to develop stabilized helical peptide th...
Show More
Edge Rankings

Stock Score Locked: Want to See it?

Benzinga Rankings give you vital metrics on any stock – anytime.

Reveal Full Score

Compare

EPS worse than industry
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

FAQ

Q

How do I buy Parabilis Medicines (PBLS) stock?

A

You can purchase shares of Parabilis Medicines (NASDAQ:PBLS) through any online brokerage.

View our list of the best stock brokerages

Q

Who are Parabilis Medicines (PBLS) competitors?

A

There are no as such competitors for Parabilis Medicines.

Q

What is the forecast, or price target, for Parabilis Medicines (PBLS) stock?

A

There is no analysis for Parabilis Medicines to provide a consensus price target.

Q

What is the current price for Parabilis Medicines (PBLS)?

A

The stock price for Parabilis Medicines (NASDAQ: PBLS) is $29.29 last updated June 17, 2026 at 9:03 AM EDT.

Q

Does Parabilis Medicines (PBLS) pay a dividend?

A

There are no upcoming dividends for Parabilis Medicines.

Q

When is Parabilis Medicines (NASDAQ:PBLS) reporting earnings?

A

Parabilis Medicines does not have any upcoming earnings scheduled.

Q

Is Parabilis Medicines (PBLS) going to split?

A

There is no upcoming split for Parabilis Medicines.

Q

What sector and industry does Parabilis Medicines (PBLS) operate in?

A

Parabilis Medicines is in the Healthcare sector and Biotechnology industry. They are listed on the NASDAQ.